Lam Research Corporation $LRCX Shares Sold by Roberts Capital Advisors LLC

Roberts Capital Advisors LLC cut its stake in shares of Lam Research Corporation (NASDAQ:LRCX) by 50.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,115 shares of the semiconductor company’s stock after selling 7,115 shares during the quarter. Lam Research accounts for approximately 1.1% of Roberts Capital Advisors LLC’s holdings, making the stock its 26th biggest position. Roberts Capital Advisors LLC’s holdings in Lam Research were worth $953,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Howard Hughes Medical Institute purchased a new stake in shares of Lam Research in the second quarter valued at about $27,000. Strategic Wealth Investment Group LLC purchased a new position in Lam Research during the second quarter worth about $29,000. Delos Wealth Advisors LLC purchased a new position in Lam Research during the second quarter worth about $30,000. Country Trust Bank acquired a new stake in Lam Research in the second quarter valued at about $39,000. Finally, Sound Income Strategies LLC acquired a new stake in Lam Research in the third quarter valued at about $41,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

LRCX has been the subject of several research analyst reports. Citic Securities increased their price objective on Lam Research from $165.00 to $275.00 and gave the stock a “buy” rating in a research report on Friday, January 30th. Weiss Ratings restated a “buy (b)” rating on shares of Lam Research in a research report on Monday, December 29th. Evercore set a $275.00 price target on shares of Lam Research in a research note on Thursday, January 29th. Needham & Company LLC increased their price target on shares of Lam Research from $250.00 to $300.00 and gave the company a “buy” rating in a report on Thursday, January 29th. Finally, Barclays raised their price objective on shares of Lam Research from $250.00 to $255.00 and gave the company an “equal weight” rating in a research note on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $245.35.

Insider Buying and Selling at Lam Research

In other Lam Research news, insider Ava Harter sold 4,000 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $232.50, for a total transaction of $930,000.00. Following the transaction, the insider owned 54,705 shares of the company’s stock, valued at $12,718,912.50. This represents a 6.81% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Eric Brandt sold 35,000 shares of the firm’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the sale, the director owned 253,705 shares in the company, valued at $57,235,848. This trade represents a 12.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 130,886 shares of company stock worth $29,658,802. Insiders own 0.31% of the company’s stock.

Lam Research Price Performance

NASDAQ:LRCX opened at $218.87 on Thursday. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $256.68. The firm has a market cap of $273.32 billion, a price-to-earnings ratio of 44.85, a price-to-earnings-growth ratio of 2.32 and a beta of 1.77. The company’s 50-day moving average is $223.44 and its two-hundred day moving average is $171.66. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. The business had revenue of $5.34 billion during the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The company’s quarterly revenue was up 22.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Research analysts expect that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be paid a $0.26 dividend. This represents a $1.04 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s payout ratio is presently 21.31%.

More Lam Research News

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Long‑term collaboration with IBM to advance sub‑1nm logic scaling — strengthens Lam’s position on next‑generation logic and EUV-related process work, expanding addressable content per wafer fab cycle. IBM and Lam Research Announce Collaboration to Advance Sub‑1nm Logic Scaling
• Positive Sentiment: S&P 100 inclusion, recent strong results and supportive market notes should boost demand — index addition and re‑rating flows plus solid Jan quarter results and guidance increase passive and active buying pressure. Lam Research jumps amid semiconductor-equipment rebound and S&P 100 addition
• Positive Sentiment: Industry capex outlook remains strong — banks raised chip‑gear spending estimates and analyst notes point to sustained WFE upside, supporting equipment vendors like Lam. Chip Gear Spending Shows No Signs Of Slowing
• Positive Sentiment: Short interest in LRCX fell meaningfully in February (≈20.7% decline), reducing immediate short‑squeeze risk and removing some downward pressure on the shares.
• Positive Sentiment: Analyst support and higher price targets remain widespread (median targets above current levels; Barclays nudged its PT higher), providing additional directional support. Barclays raises LRCX price target
• Neutral Sentiment: Independent equity research continues to highlight a favorable WFE cycle and Lam’s potential for share gains — useful context for medium‑term investors but not an immediate catalyst. Lam Research: The Setup Keeps Getting Stronger
• Negative Sentiment: Hazeltree reports hedge funds ramping short bets amid geopolitical and private‑credit concerns — broader market volatility and flow shifts could pressure cyclicals like Lam in risk‑off episodes. Hazeltree Finds Hedge Funds Ramp Up Short Bets
• Negative Sentiment: Notable insider selling activity reported across senior executives over the past six months — raises a governance/optics flag for some investors and can weigh on sentiment. Quiver Quant on LRCX insider activity

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.